Experts In The News
Biogen is pushing its experimental Alzheimer’s drug diranersen into Phase 3 trials despite missing the primary dose-response goal in its 416-patient CELIA study, after the lowest tested dose paradoxically delivered the strongest results—slowing cognitive decline on the CDR-SB scale by 26% over 18 months.
On August 10, the University of Nevada-Las Vegas announced an oral-history project profiling 10 Nevada bookmakers, still to be named. The interviews will be conducted by gaming historian David G. Schwartz and veteran casino executive and regulator Richard Schuetz.
A neonatal intensive care unit that serves some of the region’s most vulnerable newborns is set to close in Henderson, reducing the number of NICUs available in Clark County.
Make an informed choice on the best way to hydrate.
The State of Texas's latest takeovers of four school districts, including Fort Worth, Beaumont, Lake Worth, and Connally Independent School Districts (ISDs) have already had a direct cost to local taxpayers.
For decades, the South Asian diaspora in the United States has been celebrated as an exemplary economic success story and a “model minority.” However, behind the high median incomes and professional and academic accolades lies a simmering, intensifying public health emergency.
A UNLV professor and doctor is explaining what he says will be the long-term impact of President Donald Trump's executive order on childhood vaccine recommendations.
With fewer than 100 days until the November 3 general election, it’s time again to brace for a fresh wave of campaign signs, mailers and attack ads.